Camila Fátima Biancardi Gavioli
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Camila Fátima Biancardi Gavioli has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Giovanna Piacenza Florezi
Universidade de São Paulo, Brasil; Universidade de São Paulo, Brasil
3 shared publications - Marcello Menta Simonsen Nico
Department of Dermatology, Faculty of Medicine, Universidade de São Paulo, São Paulo, SP, Brazil
3 shared publications - Silvia Vanessa Lourenço
Department of Pathology, Faculty of Dentistry, Universidade de São Paulo, São Paulo, SP, Brazil
3 shared publications - Walmar Roncalli Pereira de Oliveira
Department of Dermatology, University of São Paulo Medical School, São Paulo, Brazil
3 shared publications - Bruno Bezerra DE Souza
Universidade Federal do Rio Grande do Norte
2 shared publications - Ricardo Romiti
Department of Dermatology, Faculty of Medicine, Universidade de São Paulo, São Paulo, SP, Brazil
2 shared publications
Latest Publications
- Open Access
- 1 September 2022
- Published by Elsevier in Anais Brasileiros de Dermatologia (Versão em Português)
- Vol. 97 (5) , 676-681
Síndrome de Melkersson‐Rosenthal em crianças e adolescentes: série de sete casos
- 1 September 2022
- Published by Elsevier in Anais Brasileiros de Dermatologia (Versão em Português)
- Vol. 97 (5) , 676-681
Open AccessSíndrome de Melkersson‐Rosenthal em crianças e adolescentes: série de sete casos
- Open Access
- 12 July 2022
- Published by Elsevier in Anais Brasileiros de Dermatologia
- Vol. 97 (5) , 676-681
Melkersson-Rosenthal syndrome in children and adolescents: a series of seven cases
- 12 July 2022
- Published by Elsevier in Anais Brasileiros de Dermatologia
- Vol. 97 (5) , 676-681
Open AccessMelkersson-Rosenthal syndrome in children and adolescents: a series of seven cases
- Open Access
- 1 May 2021
- Published by Elsevier in Anais Brasileiros de Dermatologia (Versão em Português)
- Vol. 96 (3) , 324-327
Manifestação de amiloidose sistêmica em um paciente com artrite psoriásica
- 1 May 2021
- Published by Elsevier in Anais Brasileiros de Dermatologia (Versão em Português)
- Vol. 96 (3) , 324-327
Open AccessManifestação de amiloidose sistêmica em um paciente com artrite psoriásica
- Open Access
- 1 May 2021
- Published by Elsevier in Anais Brasileiros de Dermatologia
- Vol. 96 (3) , 324-327
Systemic amyloidosis manifestation in a patient with psoriatic arthritis
- 1 May 2021
- Published by Elsevier in Anais Brasileiros de Dermatologia
- Vol. 96 (3) , 324-327
Open AccessSystemic amyloidosis manifestation in a patient with psoriatic arthritis
- 2 December 2020
- Published by Wiley in Dermatologic Therapy
- Vol. 34 (1) , e14622
Intradermal injections with 0.5% minoxidil for the treatment of female androgenetic alopecia: A randomized, placebo‐controlled trial
Background Female androgenetic alopecia is one cause of alopecia in women, although the ideal treatment for this condition remains far from defined. The objective of this study was to evaluate the efficacy and safety of intradermal injections with 0.5% minoxidil for the management of female androgenetic alopecia in a randomized, placebo‐controlled trial. Methods A total of 54 women diagnosed with female androgenetic alopecia were divided into two groups: one group received intradermal injections of 0.5% minoxidil, and the other received 0.9% saline. Biopsy, trichogram, Trichoscan® (Tricholog GmbH, Freiburg, Germany), and self‐assessment findings were used to evaluate the outcomes of treatment with minoxidil. Results In the treated group, there was a significant increase in the terminal‐to‐vellus hair ratio (P < 0.001) and in the percentage of anagen hairs (P = 0.048) and an improvement in hair loss and volume (P = 0.021 and P = 0.028, respectively). Conclusions These results show that intradermal injections with minoxidil were more effective than placebo (P < 0.001) in the treatment of female androgenetic alopecia with a good safety profile.
- 2 December 2020
- Published by Wiley in Dermatologic Therapy
- Vol. 34 (1) , e14622
Intradermal injections with 0.5% minoxidil for the treatment of female androgenetic alopecia: A randomized, placebo‐controlled trial
Background Female androgenetic alopecia is one cause of alopecia in women, although the ideal treatment for this condition remains far from defined. The objective of this study was to evaluate the efficacy and safety of intradermal injections with 0.5% minoxidil for the management of female androgenetic alopecia in a randomized, placebo‐controlled trial. Methods A total of 54 women diagnosed with female androgenetic alopecia were divided into two groups: one group received intradermal injections of 0.5% minoxidil, and the other received 0.9% saline. Biopsy, trichogram, Trichoscan® (Tricholog GmbH, Freiburg, Germany), and self‐assessment findings were used to evaluate the outcomes of treatment with minoxidil. Results In the treated group, there was a significant increase in the terminal‐to‐vellus hair ratio (P < 0.001) and in the percentage of anagen hairs (P = 0.048) and an improvement in hair loss and volume (P = 0.021 and P = 0.028, respectively). Conclusions These results show that intradermal injections with minoxidil were more effective than placebo (P < 0.001) in the treatment of female androgenetic alopecia with a good safety profile.
- 23 June 2020
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 47 (11) , 1010-1017
The histopathological spectrum of Melkersson‐Rosenthal syndrome: Analysis of 47 cases
Background: Melkersson‐Rosenthal syndrome (MRS) is a rare disease characterized by the triad of recurrent orofacial edema, relapsing facial paralysis and plicated tongue. Histopathological features of MRS have not been extensively analyzed.Methods: This study investigated the histopathological aspects of oral lesions from 47 MRS patients.Results: The most common biopsy site was the upper lip, followed by the lower lip, gingiva and palate. The most important findings were ill‐defined and well‐formed granulomas. Lymphoplasmacytic inflammatory infiltrate was seen in early and late stages of MRS. Edema, fibrosis, vasodilatation and congestion were the most common finding in the lamina propria. Gingival and palate exams also demonstrated granulomatous infiltrates. Regarding the evolution time of the disease, we demonstrated that, in initial phases, there is a lymphoplasmacytic inflammatory infiltrates, followed by a granulomatous infiltrate and, subsequently, fibrosis.Conclusion: Histopathological examination of oral lesions is helpful for the diagnosis of MRS; the absence of granulomatous inflammation does not exclude the diagnosis of syndrome. Clinical and histopathological analysis of the rare gingival and palate lesions is important, since all histopathological findings of the disease were detected in these sites.
- 23 June 2020
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 47 (11) , 1010-1017
The histopathological spectrum of Melkersson‐Rosenthal syndrome: Analysis of 47 cases
Background: Melkersson‐Rosenthal syndrome (MRS) is a rare disease characterized by the triad of recurrent orofacial edema, relapsing facial paralysis and plicated tongue. Histopathological features of MRS have not been extensively analyzed.Methods: This study investigated the histopathological aspects of oral lesions from 47 MRS patients.Results: The most common biopsy site was the upper lip, followed by the lower lip, gingiva and palate. The most important findings were ill‐defined and well‐formed granulomas. Lymphoplasmacytic inflammatory infiltrate was seen in early and late stages of MRS. Edema, fibrosis, vasodilatation and congestion were the most common finding in the lamina propria. Gingival and palate exams also demonstrated granulomatous infiltrates. Regarding the evolution time of the disease, we demonstrated that, in initial phases, there is a lymphoplasmacytic inflammatory infiltrates, followed by a granulomatous infiltrate and, subsequently, fibrosis.Conclusion: Histopathological examination of oral lesions is helpful for the diagnosis of MRS; the absence of granulomatous inflammation does not exclude the diagnosis of syndrome. Clinical and histopathological analysis of the rare gingival and palate lesions is important, since all histopathological findings of the disease were detected in these sites.
- Open Access
- 1 October 2018
- Published by FapUNIFESP (SciELO) in Anais Brasileiros de Dermatologia
- Vol. 93 (5) , 716-718
High-risk mucosal HPV types associated with squamous cell carcinoma on the nose tip in an immunocompetent young man
The oncogenic role of high-risk HPV in anogenital, head and neck, and cervical cancer is well recognized, but not in skin cancer in the general population. Some authors have demonstrated their appearance mainly on the hands and feet, particularly in the area of the nail bed, which could be due to contamination with HPV types from anogenital regions. Here, we describe a case of genital HPV associated with SCC on the nose tip in an immunocompetent young man, which was confirmed by histopathological findings and in situ hybridization. The importance of this report is to highlight the potential role of HPV in the etiology of skin cancer in an immunocompetent individual.
- 1 October 2018
- Published by FapUNIFESP (SciELO) in Anais Brasileiros de Dermatologia
- Vol. 93 (5) , 716-718
Open AccessHigh-risk mucosal HPV types associated with squamous cell carcinoma on the nose tip in an immunocompetent young man
The oncogenic role of high-risk HPV in anogenital, head and neck, and cervical cancer is well recognized, but not in skin cancer in the general population. Some authors have demonstrated their appearance mainly on the hands and feet, particularly in the area of the nail bed, which could be due to contamination with HPV types from anogenital regions. Here, we describe a case of genital HPV associated with SCC on the nose tip in an immunocompetent young man, which was confirmed by histopathological findings and in situ hybridization. The importance of this report is to highlight the potential role of HPV in the etiology of skin cancer in an immunocompetent individual.